Requiring Disclosure of Gifts and Payments to Physicians : State Efforts and a Legal Analysis of Potential Federal Action.
Discusses arguments for and against a Federal requirement that pharmaceutical companies disclose gifts and payments, and outlines existing AMA guidelines. Describes State disclosure laws already in effect and analyzes potential legal hurdles to a Federal disclosure requirement.
| Corporate Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
[Place of publication not identified] :
[publisher not identified],
2007.
|
| Series: | U.S. Congressional Research.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
| Summary: | Discusses arguments for and against a Federal requirement that pharmaceutical companies disclose gifts and payments, and outlines existing AMA guidelines. Describes State disclosure laws already in effect and analyzes potential legal hurdles to a Federal disclosure requirement. |
|---|---|
| Item Description: | Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Dec. 2010). Reuse except for individual research requires license from ProQuest, LLC. CRS Report. Electronic resource. |
| Physical Description: | 1 online resource. |